Evidence map›Paper›PMID 28831049›Full record

ArticleScientific reports2017

Treating the placenta to prevent adverse effects of gestational hypoxia on fetal brain development.

Tom J Phillips, Hannah Scott, David A Menassa, Ashleigh L Bignell, Aman Sood, Jude S Morton, Takami Akagi, Koki Azuma, Mark F Rogers, Catherine E Gilmore and 17 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 96 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. A Review of Nanotechnology for Treating Dysfunctional Placenta.Frontiers in bioengineering and biotechnology · 2022
    Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 11 institutions in 3 countries.

Tom J PhillipsSchool of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, BS10 5NB, UK.
Hannah ScottSchool of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, BS10 5NB, UK.ORCID 0000-0002-2497-549X
David A MenassaSchool of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, BS10 5NB, UK.
Ashleigh L BignellSchool of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, BS10 5NB, UK.
Aman SoodSchool of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, BS10 5NB, UK.
Jude S MortonDepartment of Obstetrics and Gynecology and Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada.
Takami AkagiDepartment of Applied Chemistry, Graduate School of Engineering, Osaka University, Osaka, 565-0871, Japan.
Koki AzumaDepartment of Applied Chemistry, Graduate School of Engineering, Osaka University, Osaka, 565-0871, Japan.
Mark F RogersIntelligent Systems Laboratory, University of Bristol, Merchant Venturers Building, Bristol, BS8 1UB, UK.
Catherine E GilmoreSchool of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, BS10 5NB, UK.
Gareth J InmanDivision of Cancer Research, Jacqui Wood Cancer Centre, University of Dundee, Dundee, DD1 9SY, UK.
Simon GrantDepartment of Obstetrics, Southmead Hospital, Bristol, BS10 5NB, UK.
Yealin ChungSchool of Social and Community Medicine, University of Bristol, Southmead Hospital, Bristol, BS10 5NB, UK.
Mais M AljunaidyDepartment of Obstetrics and Gynecology and Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada.
Christy-Lynn CookeDepartment of Obstetrics and Gynecology and Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada.
Bruno R SteinkrausWeatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
Andrew PocklingtonInstitute of Psychological Medicine and Clinical Neurosciences and MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, CF24 4HQ, UK.ORCID 0000-0002-2137-0452
Angela LoganMRC Mitochondrial Biology Unit, Wellcome Trust/MRC Building, Cambridge, CB2 0XY, UK.
Gavin P CollettNuffield Department of Obstetrics & Gynaecology, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Helena KempDepartment of Clinical Biochemistry, Pathology Sciences Laboratory, Southmead Hospital, Bristol, BS10 5NB, UK.
Peter A HolmansInstitute of Psychological Medicine and Clinical Neurosciences and MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, CF24 4HQ, UK.
Michael P MurphyMRC Mitochondrial Biology Unit, Wellcome Trust/MRC Building, Cambridge, CB2 0XY, UK.
Tudor A FulgaWeatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK.
Andrew M ConeyInstitute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
Mitsuru AkashiDepartment of Applied Chemistry, Graduate School of Engineering, Osaka University, Osaka, 565-0871, Japan.
Sandra T DavidgeDepartment of Obstetrics and Gynecology and Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada.
C Patrick CaseSchool of Clinical Sciences, University of Bristol, Southmead Hospital, Bristol, BS10 5NB, UK. c.p.case@bristol.ac.uk.
Southmead Hospital · GBUniversity of Alberta · CACardiff University · GBMRC Mitochondrial Biology Unit · GBUbe Frontier University · JPUniversity of Oxford · GBJohn Radcliffe Hospital · GBThe University of Osaka · JPUniversity of Birmingham · GBUniversity of Bristol · GBUniversity of Dundee · GB

Funding

Medical Research Council G0801418Medical Research Council G0902418Medical Research Council MC_U105663142Medical Research Council MC_UU_00015/3Medical Research Council MR/L010305/1Medical Research Council MR/P005748/1
6 · The paper itself

Abstract

Some neuropsychiatric disease, including schizophrenia, may originate during prenatal development, following periods of gestational hypoxia and placental oxidative stress. Here we investigated if gestational hypoxia promotes damaging secretions from the placenta that affect fetal development and whether a mitochondria-targeted antioxidant MitoQ might prevent this. Gestational hypoxia caused low birth-weight and changes in young adult offspring brain, mimicking those in human neuropsychiatric disease. Exposure of cultured neurons to fetal plasma or to secretions from the placenta or from model trophoblast barriers that had been exposed to altered oxygenation caused similar morphological changes. The secretions and plasma contained altered microRNAs whose targets were linked with changes in gene expression in the fetal brain and with human schizophrenia loci. Molecular and morphological changes in vivo and in vitro were prevented by a single dose of MitoQ bound to nanoparticles, which were shown to localise and prevent oxidative stress in the placenta but not in the fetus. We suggest the possibility of developing preventative treatments that target the placenta and not the fetus to reduce risk of psychiatric disease in later life.

Indexed as

Fetal DevelopmentAnimalsAntioxidantsBiomarkersBrainFemaleFetusGene ExpressionHypoxiaMicroscopy, ConfocalOrganogenesisOxidative StressPlacentaPregnancyPregnancy ComplicationsRatsAntioxidantsBiomarkersReactive Oxygen Species

Identifiers

PMID28831049
PMCPMC5567270
OpenAlexW2747135489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.